EcoPhage Overview
EcoPhage is focused on discovering and developing environmentally friendly products for disease control in agriculture. The company's technology uses bacteriophages (viruses that attack bacteria) for crop protection. The technology was developed by Professor Rotem Sorek of Israel's Weizmann Institute of Science. Based on the discoveries made by Professor Sorek and now held by EcoPhage for crop protection under exclusive license from Yeda, the company is poised to develop effective, eco-friendly treatments against crop diseases. The company was formed as a joint venture between the Bayer Trendlines Ag Innovation Fund and Trendlines Group.
Cumulative Funding Raised Over Time ($)
—Jul 2019
Latest News
growth-positive
/PRNewswire/ -- EcoPhage, a leader in the development and commercialization of sustainable phage-based biopesticides for bacterial plant diseases, expecting...
EcoPhage, a leader in sustainable phage-based biopesticides, has appointed José Alfredo García to its Board of Directors. Garcías extensive experience in global agribusiness and his focus on innovation and sustainable inputs will be instrumental as EcoPhage prepares for its commercial rollout. The company is expecting its first U.S. EPA approval and aims to transform the agricultural bactericide market with its bacteriophage-based solutions. Co-developed with the Weizmann Institute of Science, EcoPhages technology offers nontoxic solutions for bacterial plant diseases, promoting ecological balance and increasing crop yields.
Management ChangesProduct Stage
growth-positive
EcoPhage and Maian have entered into a distribution agreement for Brazil
EcoPhage, a leader in bacteriophage-based bactericides, has entered into a distribution agreement with Maian Ltda to market its GoldenEco product in Brazil. GoldenEco is designed to control bacterial diseases in tomatoes and peppers, offering a natural and residue-free alternative to copper and antibiotics. This partnership with Maian, a global company specializing in sustainable raw materials, positions EcoPhage to tap into Brazils significant agricultural market. The collaboration is expected to enhance EcoPhages market presence and contribute to sustainable agricultural practices. Both companies express optimism about the partnerships potential to transform the market and improve crop yields.
Partners
growth-positive
8 Israeli inventions for greener farming
The article discusses the growing demand for eco-friendly agricultural technology in light of food security concerns and the goal of the European Union to reduce chemical pesticide use by 50% by 2030. Several Israeli agtech companies, including BioBee Biological Systems, Groundwork BioAg, N-Drip, AgroScout, Greeneye Technology, WeedOUT, EcoPhage, and IBI-Ag, are developing solutions to address these issues. These companies are receiving investments from international investors and corporate giants such as Monsanto, Syngenta, and Bayer, as well as domestic support from the government and several funds and accelerators, including Jerusalem Venture Partners’ food-tech/agtech fund and innovation commercialization company Trendlines Group.
InvestmentPartners
growth-positive
Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company
Bayer Trendlines Ag Innovation Fund has established EcoPhage Ltd., a new company focused on developing environmentally friendly products for disease control in agriculture. EcoPhage will leverage a disruptive technology using bacteriophages for crop protection. The technology was developed by Professor Rotem Sorek of Israels Weizmann Institute of Science. The company aims to develop effective, eco-friendly treatments against crop diseases. The establishment of EcoPhage is a growth-positive move for the company. The Bayer Trendlines Ag Innovation Fund is a collaborative partnership between Bayer and The Trendlines Group, with a US$10 million investment from Bayer.
PartnersInvestment
| Sector | Agriculture & Food Technologies |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 2 |
| Investors | 2 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | ecophage.com |
Locations
Pinhas Sapir St 3, Ness Ziona, 7403626, Israel
Photos & Videos
1 item(s)
EcoPhage Business
Business models
B2B
Product stage
R&D
Employees
1-10
Sector
Agriculture & Food TechnologiesAg TechFarm Equipment & TreatmentClimate TechFood & Land UseSustainable FarmingTarget Customer
Agriculture & FoodCropsCore Technology
BiologicalsTags (6)
climate-techdisease-managementbiotechnologycropsplant-protectionagtechEcoPhage Financials
Undisclosed
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Seed
Funding stage
2
Total rounds
2
Investors
Cumulative Funding Raised Over Time ($)
—Jul 2019
Private Equity Funding
Undisclosed Round
Jul 2019
Undisclosed
Bayer Trendlines Ag Innovation Fund , The Trendlines Group
Non-Equity Funding
GrantEvent
Aug 2022
Undisclosed
Israel Innovation Authority
EcoPhage Lifecycle
Cumulative Funding Raised Over Time
—Jul 2019
All Events
Undisclosed Round
Jul 2019
Undisclosed
Bayer Trendlines Ag Innovation Fund , The Trendlines Group
GrantEvent
Aug 2022
Undisclosed
Israel Innovation Authority
EcoPhage News
4 articles
growth-positive
/PRNewswire/ -- EcoPhage, a leader in the development and commercialization of sustainable phage-based biopesticides for bacterial plant diseases, expecting...
EcoPhage, a leader in sustainable phage-based biopesticides, has appointed José Alfredo García to its Board of Directors. Garcías extensive experience in global agribusiness and his focus on innovation and sustainable inputs will be instrumental as EcoPhage prepares for its commercial rollout. The company is expecting its first U.S. EPA approval and aims to transform the agricultural bactericide market with its bacteriophage-based solutions. Co-developed with the Weizmann Institute of Science, EcoPhages technology offers nontoxic solutions for bacterial plant diseases, promoting ecological balance and increasing crop yields.
Management ChangesProduct Stage
growth-positive
EcoPhage and Maian have entered into a distribution agreement for Brazil
EcoPhage, a leader in bacteriophage-based bactericides, has entered into a distribution agreement with Maian Ltda to market its GoldenEco product in Brazil. GoldenEco is designed to control bacterial diseases in tomatoes and peppers, offering a natural and residue-free alternative to copper and antibiotics. This partnership with Maian, a global company specializing in sustainable raw materials, positions EcoPhage to tap into Brazils significant agricultural market. The collaboration is expected to enhance EcoPhages market presence and contribute to sustainable agricultural practices. Both companies express optimism about the partnerships potential to transform the market and improve crop yields.
Partners
growth-positive
8 Israeli inventions for greener farming
The article discusses the growing demand for eco-friendly agricultural technology in light of food security concerns and the goal of the European Union to reduce chemical pesticide use by 50% by 2030. Several Israeli agtech companies, including BioBee Biological Systems, Groundwork BioAg, N-Drip, AgroScout, Greeneye Technology, WeedOUT, EcoPhage, and IBI-Ag, are developing solutions to address these issues. These companies are receiving investments from international investors and corporate giants such as Monsanto, Syngenta, and Bayer, as well as domestic support from the government and several funds and accelerators, including Jerusalem Venture Partners’ food-tech/agtech fund and innovation commercialization company Trendlines Group.
InvestmentPartners
growth-positive
Bayer Trendlines Ag Innovation Fund to Co-invest With Trendlines in New Company
Bayer Trendlines Ag Innovation Fund has established EcoPhage Ltd., a new company focused on developing environmentally friendly products for disease control in agriculture. EcoPhage will leverage a disruptive technology using bacteriophages for crop protection. The technology was developed by Professor Rotem Sorek of Israels Weizmann Institute of Science. The company aims to develop effective, eco-friendly treatments against crop diseases. The establishment of EcoPhage is a growth-positive move for the company. The Bayer Trendlines Ag Innovation Fund is a collaborative partnership between Bayer and The Trendlines Group, with a US$10 million investment from Bayer.
PartnersInvestment
EcoPhage Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 10 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.
EcoPhage Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 99/100 |
| Missing | markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515947091 |
| Crunchbase | EcoPhage |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Ortal Wein |
| Updater email | ortalw@sncentral.org |
| Last update | 2023-06-05T00:00:00.000Z |
| Created | 2019-07-10T00:00:00.000Z |